Verition Fund Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$247K 3816
2024
Q4
$247K Buy
+20,000
New +$229K ﹤0.01% 2873
2021
Q4
Sell
-65,000
Closed -$1.4M 2855
2021
Q3
$1.4M Buy
+65,000
New +$1.57M 0.01% 793

Other funds holding CDMO

Verition Fund Management's CDMO Position: Q1 2025 in Review

Verition Fund Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 20,103 shares — an estimated $248K sold.

Verition Fund Management first reported a position in CDMO in Q2 2021 and held it in 7 quarters. The position peaked at $1.01M in Q3 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Verition Fund Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 20,103 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $248K.
  • Verition Fund Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Verition Fund Management's Avid Bioservices, Inc. Common Stock position peaked at $1.01M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.